GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps
Launched by UNIVERSITY OF ULM · Nov 2, 2015
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
Colorectal cancer ist the 2nd most leading cancer among men and women in germany. Screening colonoscopy is provided for all people over 55 years in germany to detect and remove precancerous lesions (polyps) and thereby prevent the occurence of colorectal cancers. According to the result of screening colonoscopy and histopathological examination of the removed polyps the next examination will be planned. But so called interval carcinomas were observed with increasing incidence. Thus, further tools and mechanisms, beyond but in addition to endoscopy and histopathology, are strongly required t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • written informed consent
- • indication of screening colonoscopy
- Exclusion Criteria:
- • chronic inflammatory bowl disease
- • known colorectal cancer (except curative treated colorectal cancers more than 5 years ago)
- • disagreement in participation
About University Of Ulm
The University of Ulm is a leading academic institution located in Germany, renowned for its commitment to cutting-edge research and innovation in the fields of medicine and health sciences. As a clinical trial sponsor, the university leverages its robust network of researchers and clinical experts to advance medical knowledge and improve patient outcomes. With a focus on interdisciplinary collaboration, the University of Ulm conducts comprehensive clinical studies that adhere to the highest ethical standards and regulatory guidelines. Through its research initiatives, the university aims to contribute significantly to the development of new therapies and treatment modalities, fostering a deeper understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, Steiermark, Austria
Dornstadt, Baden Württemberg, Germany
Ulm, Baden Württemberg, Germany
Munich, Bavaria, Germany
Dornstadt, , Germany
Ulm, , Germany
Patients applied
Trial Officials
Alexander G. Meining, Prof. Dr.
Principal Investigator
University Ulm, Internal Medicine I, Interventional and experimental endoscopy (InExEn)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials